The Long Noncoding RNA Chaer Defines an Epigenetic Checkpoint in Cardiac Hypertrophy

Zhihua Wang,Xiao-Jing Zhang,Yan-Xiao Ji,Peng Zhang,Ke-Qiong Deng,Jun Gong,Shuxun Ren,Xinghua Wang,Iris Chen,He Wang,Chen Gao,Tomohiro Yokota,Yen Sin Ang,Shen Li,Ashley Cass,Thomas M Vondriska,Guangping Li,Arjun Deb,Deepak Srivastava,Huang-Tian Yang,Xinshu Xiao,Hongliang Li,Yibin Wang
DOI: https://doi.org/10.1038/nm.4179
IF: 82.9
2016-01-01
Nature Medicine
Abstract:The lncRNA Chaer controls hypertrophic heart growth by binding to and interfering with the function of the epigenetic regulator PRC2. Epigenetic reprogramming is a critical process of pathological gene induction during cardiac hypertrophy and remodeling, but the underlying regulatory mechanisms remain to be elucidated. Here we identified a heart-enriched long noncoding (lnc)RNA, named cardiac-hypertrophy-associated epigenetic regulator (Chaer), which is necessary for the development of cardiac hypertrophy. Mechanistically, Chaer directly interacts with the catalytic subunit of polycomb repressor complex 2 (PRC2). This interaction, which is mediated by a 66-mer motif in Chaer, interferes with PRC2 targeting to genomic loci, thereby inhibiting histone H3 lysine 27 methylation at the promoter regions of genes involved in cardiac hypertrophy. The interaction between Chaer and PRC2 is transiently induced after hormone or stress stimulation in a process involving mammalian target of rapamycin complex 1, and this interaction is a prerequisite for epigenetic reprogramming and induction of genes involved in hypertrophy. Inhibition of Chaer expression in the heart before, but not after, the onset of pressure overload substantially attenuates cardiac hypertrophy and dysfunction. Our study reveals that stress-induced pathological gene activation in the heart requires a previously uncharacterized lncRNA-dependent epigenetic checkpoint.
What problem does this paper attempt to address?